Loading
Christian doctors lament another abortion drug death

.- The 17,000-member Christian Medical Association is calling on the Food and Drug Administration to pull an abortion drug for safety review after yet another two women died using the drug. Mifeprex, or RU-486, has been linked to the deaths of at least five women since it was approved for use in 2000.

The Christian Medical Association’s appeal was issued July 20, one day after the FDA issued a public health advisory, alerting all doctors to be on the lookout for infections in women using the drug. Women may not have typical symptoms, such as a fever.

Eight months ago, the FDA warned about two sepsis cases associated with Mifeprex. Additional sepsis cases were reported to the agency in April and June.

"With every death of another woman due to RU-486, the FDA's mandate grows clearer—to pull this drug for an objective safety review,” said Dr. David Stevens, executive director of the Christian Medical Association. He said the medical association laments the tragic loss of lives of these women and the thousands of unborn babies killed by this drug.

RU-486 was initially approved “through a scientifically deficient and politically corrupted process,” he stated.

“We documented that corrupt and deficient process in a 90-page brief submitted three years ago, calling on the FDA to pull the drug for review,” he said. “The FDA has all the information it needs to get this dangerous drug off the shelves to protect the lives and health of American women.”

Stevens colleague and associate director, Dr. Gene Rudd, said many women “have suffered in other ways after using this pill.” He said many women live in pain and guilt after aborting their baby.

He urged women in crisis pregnancies to seek support from churches and crisis pregnancy centers. Women seeking such help can also call: 1-800-395-HELP.


Ads by AdsLiveMedia(What's this?)

* The number of messages that can be online is limited. CNA reserves the right to edit messages for content and tone. Comments and opinions expressed by users do not necessarily reflect the opinions or beliefs of CNA. CNA will not publish comments with abusive language, insults or links to other pages

RESOURCES »

Ads by Google (What's this?)
Ads by Google (What's this?)

Featured Videos

Pope Francis celebrates the closing Mass and announces site of next World Youth Day
Pope Francis celebrates the closing Mass and announces site of next World Youth Day
Pope Francis visits poor neighborhood and meets with young people from Argentina
Pope Francis celebrates Mass at the National Shrine of Our Lady of Aparecida
Denver rally draws hundreds in support of religious freedom
Pope Francis prays over a sick man in St Peter's Square
Denver women's clinic will offer natural, Catholic care
Interview Clips: Barbara Nicolosi speaks to CNA
US Cardinals press conference at North American College
Pope Benedict to retire to monastery inside Vatican City
Pope cites waning strength as reason for resignation
Hundreds convene in Denver to urge respect for life
New Orange bishop encourages Catholic unity in diversity
Chinese pro-life activist calls for reform, international attention
At Lincoln installation, Bishop Conley says holiness is success
Mother Cabrini shrine reopens in Chicago after a decade
Ordination of 33 deacons fills St. Peter's with joy
Cardinal says "Charity is the mother of all the virtues"
Augustine Institute expands evangelization effort with new campus
Bishops recall 'Way of St. James' as chance to trust in God
Los Angeles cathedral's newest chapel houses Guadalupe relic
Apr
23

Liturgical Calendar

April 23, 2014

Wednesday within the Octa ve of Easter

All readings:
Today »
This year »

Catholic Daily

Gospel of the Day

Mt 28:8-15

Gospel
Date
04/22/14
04/21/14
04/20/14

Daily Readings


First Reading:: Acts 3:1-10
Gospel:: Lk 24:13-35

Saint of the Day

St. Adalbert of Prague »

Saint
Date
04/21/14
04/20/14

Homily of the Day

Mt 28:8-15

Homily
Date
04/22/14
04/21/14
04/20/14

Ads by AdsLiveMedia.com

Ads by AdsLiveMedia.com
     HTML
Text only
Headlines
  

Follow us: